Morgan Stanley Maintains Equal-Weight on UiPath, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Keith Weiss maintains an Equal-Weight rating on UiPath (NYSE:PATH) but lowers the price target from $25 to $15.
May 30, 2024 | 5:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley analyst Keith Weiss maintains an Equal-Weight rating on UiPath but lowers the price target from $25 to $15.
The lowered price target from $25 to $15 by a major analyst like Morgan Stanley is likely to negatively impact investor sentiment and could lead to a short-term decline in UiPath's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100